• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1A 型腓骨肌萎缩症患者的疼痛患病率及特征。

Prevalence and characterization of pain in patients with Charcot-Marie-Tooth disease type 1A.

机构信息

Universidade Federal Fluminense, Hospital Universitário Antônio Pedro, Departamento de Neurologia, Niterói RJ, Brasil.

出版信息

Arq Neuropsiquiatr. 2021 May;79(5):415-419. doi: 10.1590/0004-282X-ANP-2020-0132.

DOI:10.1590/0004-282X-ANP-2020-0132
PMID:34037101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9394555/
Abstract

BACKGROUND

Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common form of hereditary neuropathy.

OBJECTIVE

To investigate the prevalence and characteristics of pain in patients with CMT1A.

METHODS

Nineteen patients with a diagnosis of CMT1A were evaluated between September 2018 and October 2019, and other causes of neuropathy were ruled out. The following tools were used for the pain assessment: neurological assessment, LANSS, DN4, clinical evaluation, VAS, CMTNS2 and SF-36. Statistical analysis was performed using prevalence analysis, t test, chi-square test and Spearman's rho.

RESULTS

The prevalence of pain was 84.2% in the sample of this study, with moderate intensity and nociceptive characteristics according to the LANSS scale (75%) and clinical evaluation (50%), but differing from DN4, which found neuropathic pain in the majority of the patients (56.2%). Mixed pain was also observed in 43.7% of the patients, according to clinical criteria. There was a statistically significant correlation between pain intensity and SF-36, thus demonstrating that the lower the pain was, the lower the impairment was, in all domains.

CONCLUSION

Pain is a prevalent and important symptom in CMT1A, with moderate intensity and nociceptive characteristics according to two tools, but neuropathic pain is also present, and there may even be a mixed pattern of pain. The correlation of the pain with SF-36 suggests that pain relief could provide improvements to the quality of life of these individuals.

摘要

背景

Charcot-Marie-Tooth 病 1A 型(CMT1A)是最常见的遗传性周围神经病。

目的

调查 CMT1A 患者疼痛的患病率和特征。

方法

2018 年 9 月至 2019 年 10 月间评估了 19 例 CMT1A 患者,并排除了其他神经病变的原因。采用以下工具进行疼痛评估:神经学评估、LANSS、DN4、临床评估、VAS、CMTNS2 和 SF-36。采用患病率分析、t 检验、卡方检验和斯皮尔曼 rho 进行统计学分析。

结果

在本研究样本中,疼痛的患病率为 84.2%,根据 LANSS 量表(75%)和临床评估(50%),疼痛强度为中度,具有伤害感受性特征,但与 DN4 不同,DN4 发现大多数患者存在神经病理性疼痛(56.2%)。根据临床标准,还观察到混合性疼痛占 43.7%。疼痛强度与 SF-36 之间存在统计学显著相关性,因此表明疼痛越低,所有领域的损伤越低。

结论

疼痛是 CMT1A 的一种常见且重要的症状,根据两种工具,疼痛强度为中度,具有伤害感受性特征,但也存在神经病理性疼痛,甚至可能存在混合性疼痛模式。疼痛与 SF-36 的相关性表明,缓解疼痛可能会提高这些患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9022/9394555/ea705c1a81eb/1678-4227-anp-79-05-0415-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9022/9394555/ea705c1a81eb/1678-4227-anp-79-05-0415-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9022/9394555/ea705c1a81eb/1678-4227-anp-79-05-0415-gf1.jpg

相似文献

1
Prevalence and characterization of pain in patients with Charcot-Marie-Tooth disease type 1A.1A 型腓骨肌萎缩症患者的疼痛患病率及特征。
Arq Neuropsiquiatr. 2021 May;79(5):415-419. doi: 10.1590/0004-282X-ANP-2020-0132.
2
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study.腓骨肌萎缩症 1A 患者神经病理性疼痛的机制:一项基于激光诱发电位的研究。
Pain. 2010 May;149(2):379-385. doi: 10.1016/j.pain.2010.03.001. Epub 2010 Mar 23.
3
Neuropathic pain in patients with Charcot-Marie-Tooth type 1A.腓骨肌萎缩症 1A 型患者的神经病理性疼痛。
Neurol Sci. 2020 Mar;41(3):625-630. doi: 10.1007/s10072-019-04142-5. Epub 2019 Nov 15.
4
Pain assessment in Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth(CMT)病的疼痛评估。
Ann Phys Rehabil Med. 2012 Apr;55(3):160-73. doi: 10.1016/j.rehab.2012.02.005. Epub 2012 Mar 6.
5
The impact of symptoms on daily life as perceived by patients with Charcot-Marie-Tooth type 1A disease.Charcot-Marie-Tooth 型 1A 病患者感知的症状对日常生活的影响。
Neurol Sci. 2022 Jan;43(1):559-563. doi: 10.1007/s10072-021-05254-7. Epub 2021 Apr 26.
6
Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A.遗传性压迫易发性神经病患者的生活质量与 1A 型腓骨肌萎缩症患者相当差。
Acta Neurol Belg. 2021 Dec;121(6):1481-1486. doi: 10.1007/s13760-020-01355-w. Epub 2020 Apr 25.
7
Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.运动机能恶化在 50 岁后在 1A 型腓骨肌萎缩症患者中加速。
Eur J Neurol. 2018 Feb;25(2):301-306. doi: 10.1111/ene.13494. Epub 2017 Dec 14.
8
Neuropathic pain in Charcot-Marie-Tooth disease: A clinical and laser-evoked potential study.Charcot-Marie-Tooth 病中的神经性疼痛:一项临床和激光诱发电位研究。
Eur J Pain. 2022 Apr;26(4):929-936. doi: 10.1002/ejp.1922. Epub 2022 Feb 17.
9
High glucose level as a modifier factor in CMT1A patients.高血糖水平作为 CMT1A 患者的修饰因子。
J Peripher Nerv Syst. 2020 Jun;25(2):132-137. doi: 10.1111/jns.12379. Epub 2020 May 12.
10
Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.应用磁共振神经成像技术对 1A 型遗传性运动感觉神经病患者坐骨神经改变进行定量评估。
Eur J Neurol. 2020 Aug;27(8):1382-1389. doi: 10.1111/ene.14303. Epub 2020 Jun 3.

引用本文的文献

1
Charcot-Marie-Tooth disease: from historical landmarks in Brazil to current care perspectives.Charcot-Marie-Tooth 病:从巴西的历史里程碑到当前的护理视角。
Arq Neuropsiquiatr. 2023 Oct;81(10):913-921. doi: 10.1055/s-0043-1770348. Epub 2023 Aug 23.

本文引用的文献

1
Pain and pain syndromes.疼痛与疼痛综合征。
Br J Hosp Med (Lond). 2018 Aug 2;79(8):449-453. doi: 10.12968/hmed.2018.79.8.449.
2
Pain in Charcot-Marie-Tooth disease: an update.夏科-马里-图思病中的疼痛:最新进展
Arq Neuropsiquiatr. 2018 Apr;76(4):273-276. doi: 10.1590/0004-282x20180021.
3
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.中间型遗传性运动感觉神经病:电生理学再评估和系统综述。
J Neurol. 2017 Aug;264(8):1655-1677. doi: 10.1007/s00415-017-8474-3. Epub 2017 Mar 31.
4
Neuropathic pain.神经性疼痛。
Nat Rev Dis Primers. 2017 Feb 16;3:17002. doi: 10.1038/nrdp.2017.2.
5
Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.由MPZ基因突变引起的遗传性神经病的基因型-表型特征及基线自然病史。
Brain. 2015 Nov;138(Pt 11):3180-92. doi: 10.1093/brain/awv241. Epub 2015 Aug 25.
6
Charcot-Marie-Tooth disease and other inherited neuropathies.夏科-马里-图思病及其他遗传性神经病。
Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1208-25. doi: 10.1212/01.CON.0000455885.37169.4c.
7
Is overwork weakness relevant in Charcot-Marie-Tooth disease?过度劳累相关性肌无力与 Charcot-Marie-Tooth 病有关吗?
J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1354-8. doi: 10.1136/jnnp-2014-307598. Epub 2014 Mar 21.
8
Pain and small fiber function in Charcot-Marie-Tooth disease type 1A.
Muscle Nerve. 2014 Sep;50(3):366-71. doi: 10.1002/mus.24169. Epub 2014 May 15.
9
Pain assessment in Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth(CMT)病的疼痛评估。
Ann Phys Rehabil Med. 2012 Apr;55(3):160-73. doi: 10.1016/j.rehab.2012.02.005. Epub 2012 Mar 6.
10
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.CMT 神经病评分(第二版)在 Charcot-Marie-Tooth 病中的可靠性。
J Peripher Nerv Syst. 2011 Sep;16(3):191-8. doi: 10.1111/j.1529-8027.2011.00350.x.